ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE
    2.
    发明授权
    ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE 有权
    ACYLOXYALKYLCARBAMAT-PRODRUGS,SYNTHESEVERFAHREN UND ANWENDUNG

    公开(公告)号:EP1660440B1

    公开(公告)日:2012-02-22

    申请号:EP04781926.3

    申请日:2004-08-20

    申请人: XenoPort, Inc.

    IPC分类号: C07C271/22 A61K31/195

    摘要: The disclosures herein relate generally to acyloxyalkyl carbamate prodrugs of (±) 4 amino 3 (4 chlorophenyl)butanoic acid and analogs thereof, pharmaceutical compositions thereof , methods of making prodrugs of (±) 4 amino 3 (4 chlorophenyl)butanoic acid and analogs thereof, methods of using prodrugs of (±) 4 amino 3 (4 chlorophenyl)butanoic acid and analogs thereof, and pharmaceutical compositions thereof for treating or preventing common diseases and/or disorders such as spasticity and/or acid reflux disease. The disclosures herein also relate to acyloxyalkyl carbamate prodrugs of (±) 4 amino 3 (4 chlorophenyl)butanoic acid and analogs thereof which are suitable for oral administration and to sustained release oral dosage forms thereof.

    摘要翻译: 本文的公开内容通常涉及(.plusmn。)4氨基3(4氯苯基)丁酸及其类似物的酰氧基烷基氨基甲酸酯前药,其药物组合物,制备(.plusmn。)4氨基3(4氯苯基)丁酸 其酸和类似物,其用于(.plusmn。)4氨基3(4氯苯基)丁酸及其类似物的前药的方法及其用于治疗或预防常见疾病和/或病症如痉挛和/或酸的药物组合物 反流疾病。 本文的公开内容还涉及适于口服给药的(.plusmn)4氨基3(4氯苯基)丁酸及其类似物的氨基氧基烷基氨基甲酸酯产物及其缓释口服剂型。

    ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE
    3.
    发明公开
    ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE 有权
    ACYLOXYALKYLCARBAMAT前体药物,合成方法和应用

    公开(公告)号:EP1660440A2

    公开(公告)日:2006-05-31

    申请号:EP04781926.3

    申请日:2004-08-20

    申请人: Xenoport, Inc.

    IPC分类号: C07C271/22 A61K31/195

    摘要: The disclosures herein relate generally to acyloxyalkyl carbamate prodrugs of (±) 4 amino 3 (4 chlorophenyl)butanoic acid and analogs thereof, pharmaceutical compositions thereof , methods of making prodrugs of (±) 4 amino 3 (4 chlorophenyl)butanoic acid and analogs thereof, methods of using prodrugs of (±) 4 amino 3 (4 chlorophenyl)butanoic acid and analogs thereof, and pharmaceutical compositions thereof for treating or preventing common diseases and/or disorders such as spasticity and/or acid reflux disease. The disclosures herein also relate to acyloxyalkyl carbamate prodrugs of (±) 4 amino 3 (4 chlorophenyl)butanoic acid and analogs thereof which are suitable for oral administration and to sustained release oral dosage forms thereof.